<p><em>新的白皮書強調健康老齡化、女性健康和代謝健康如何通過科學支持的個性化和數字化營養補充解決方案重塑預防營養的未來</em></p>
<p>, /PRNewswire/ -- 隨着全球醫療保健優先事項從反應性治療轉向主動健康和預防，營養補充品行業出現了新的增長機會。</p>
<p>在其最新的白皮書《營養補充品中的健康經濟：健康老齡化、女性健康成分和體重管理的增長機會》中，Frost &amp; Sullivan 探討了人口結構變化、代謝健康挑戰和對個性化營養需求上升如何重塑行業的未來。</p>
<p>白皮書強調，消費者、醫療保健生態系統和成分創新者越來越多地圍繞 “健康壽命” 這一概念聚集——延長健康生活的年限，而不僅僅是延長壽命。到 2030 年，全球每六個人中就有一個將年滿 60 歲，而到 2035 年，全球超過 50% 的人口預計將超重或肥胖，從而加大對以預防為導向的營養解決方案的需求。</p>
<p>“傳統的老齡化模型專注於疾病管理而非預防，正在迅速被重新定義，” Frost &amp; Sullivan 的化學、材料與營養顧問 Véronique Scordia 表示。</p>
<p>“下一個增長階段將由整合的、科學支持的解決方案主導，這些解決方案不僅延長壽命，還延長健康壽命。那些結合營養、生物技術和個性化健康洞察，以應對移動性、認知和代謝韌性的公司將塑造健康老齡化和長壽的未來。”</p>
<p>研究確定了三個高增長領域正在改變營養補充品的格局：健康老齡化、體重管理和女性健康。</p>
<p>體重管理正在超越傳統的卡路里減少策略，向更廣泛的代謝健康優化發展。報告指出，GLP-1 驅動的創新正在重塑製藥和營養補充品行業，為專注於食慾控制、飽腹感、能量調節和可持續長期健康的解決方案創造新的機會。</p>
<p>“隨着 GLP-1 通路的獲得關注，體重管理正進入一個新的生物驅動解決方案時代，” Frost &amp; Sullivan 的化學、材料與營養行業分析師 Akheela Dhiman 指出。</p>
<p>“重點正在從短期結果轉向持久的整體健康，創造醫療保健與食品和成分行業之間的新交集。”</p>
<p>白皮書還強調女性健康是行業中最具戰略意義的增長機會之一，這一機會源於對歷史上被忽視和研究不足的健康需求的日益關注，包括生育、激素健康、更年期和代謝健康。</p>
<p>“女性健康市場正在經歷結構性重置，” Frost &amp; Sullivan 的化學、材料與營養行業分析師 Nimisha Dhomne 表示。</p>
<p>“生命週期營養、基於生物標誌物的洞察和經過驗證的成分正在重塑創新優先事項，重點越來越多地放在精準性、可信度和為真實生理複雜性設計的解決方案上。”</p>
<p>Frost &amp; Sullivan 確定了幾個塑造營養補充品未來的戰略要素，包括微生物組科學的進展、生物活性成分、個性化遞送系統、數字健康整合和直銷模式。報告還強調了圍繞圍絕經期營養、多功能健康老齡化解決方案以及在快速增長的亞太和拉丁美洲市場擴大營養補充品獲取的新的增長機會。</p>
<p>報告中介紹的領先創新者包括 dsm-firmenich、Novonesis、Glanbia Nutritionals 和 Nestlé Health Science，它們因推動成分創新、微生物組科學、代謝健康和生命週期營養解決方案而受到認可。</p>
<p>要索取《營養補充品中的健康經濟：健康老齡化、女性健康成分和體重管理的增長機會》的免費副本，請點擊這裏。</p>
<p><strong>關於 Frost &amp; Sullivan</strong></p>
<p>Frost &amp; Sullivan，轉型增長公司，幫助客户加速增長，實現增長、創新和領導力方面的最佳表現。公司的增長管道即服務為首席執行官的增長團隊提供轉型戰略和最佳實踐模型，以推動強大增長機會的生成、評估和實施。超過 60 年來，Frost &amp; Sullivan 與投資者、企業領導者和政府合作，識別、優先考慮和執行轉型增長戰略。</p>
<p>Kristina Menzefricke</p>
<p>市場與傳播</p>
<p>全球客户體驗</p>
<p>[email protected]</p>
<p>來源 Frost &amp; Sullivan</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEzJk5ld3NJdGVtSWQ9REE1ODY4NyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTMxNTM1UFJfTkVXU19VU1BSX19fX19EQTU4Njg3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEzJk5ld3NJdGVtSWQ9REE1ODY4NyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTMxNTM1UFJfTkVXU19VU1BSX19fX19EQTU4Njg3"/></p>

雀巢(ADR)

雀巢

日常消費品 ETF - Vanguard

<p>Frost & Sullivan 的新白皮書探討了營養保健品中 “健康經濟” 的崛起，強調了在健康老齡化、女性健康和體重管理方面的增長機會。隨着醫療保健向主動健康管理轉變，個性化營養的需求正在增加。主要趨勢包括體重管理策略的演變和對女性健康需求的關注。報告確定了戰略要務，如微生物組科學和數字健康整合，領先的創新者如 dsm-firmenich 和雀巢健康科學正在塑造行業的未來</p>

<p><em>New whitepaper highlights how healthy aging, women's health, and metabolic wellness are reshaping the future of preventive nutrition through science-backed, personalised, and digitally enabled nutraceutical solutions</em></p>
<div class="lb-trans"><p><em>新的白皮書強調健康老齡化、女性健康和代謝健康如何通過科學支持的個性化和數字化營養補充解決方案重塑預防營養的未來</em></p>
</div><p>, /PRNewswire/ -- As global healthcare priorities shift from reactive treatment toward proactive wellness and prevention, new growth opportunities are emerging across the nutraceuticals industry.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- 隨着全球醫療保健優先事項從反應性治療轉向主動健康和預防，營養補充品行業出現了新的增長機會。</p>
</div><p>In its latest whitepaper, The Healthspan Economy in Nutraceuticals: Growth Opportunities in Healthy Aging, Women's Health Ingredients, and Weight Management, Frost &amp; Sullivan explores how demographic shifts, metabolic health challenges, and rising demand for personalized nutrition are reshaping the future of the industry.</p>
<div class="lb-trans"><p>在其最新的白皮書《營養補充品中的健康經濟：健康老齡化、女性健康成分和體重管理的增長機會》中，Frost &amp; Sullivan 探討了人口結構變化、代謝健康挑戰和對個性化營養需求上升如何重塑行業的未來。</p>
</div><p>The whitepaper highlights how consumers, healthcare ecosystems, and ingredient innovators are increasingly converging around the concept of &#34;healthspan&#34; - extending the number of years lived in good health rather than simply increasing lifespan. By 2030, one in six people globally will be aged 60 or older, while more than 50% of the global population is projected to be overweight or obese by 2035, intensifying demand for preventive, nutrition-led solutions.</p>
<div class="lb-trans"><p>白皮書強調，消費者、醫療保健生態系統和成分創新者越來越多地圍繞 “健康壽命” 這一概念聚集——延長健康生活的年限，而不僅僅是延長壽命。到 2030 年，全球每六個人中就有一個將年滿 60 歲，而到 2035 年，全球超過 50% 的人口預計將超重或肥胖，從而加大對以預防為導向的營養解決方案的需求。</p>
</div><p>&#34;The traditional model of aging focused on disease management rather than prevention is rapidly being redefined,&#34; said Véronique Scordia, Chemicals, Materials, &amp; Nutrition Consultant at Frost &amp; Sullivan.</p>
<div class="lb-trans"><p>“傳統的老齡化模型專注於疾病管理而非預防，正在迅速被重新定義，” Frost &amp; Sullivan 的化學、材料與營養顧問 Véronique Scordia 表示。</p>
</div><p>&#34;The next phase of growth will be led by integrated, science-backed solutions that extend healthspan, not just lifespan. Companies that combine nutrition, biotechnology, and personalised health insights to address mobility, cognition, and metabolic resilience will shape the future of healthy aging and longevity.&#34;</p>
<div class="lb-trans"><p>“下一個增長階段將由整合的、科學支持的解決方案主導，這些解決方案不僅延長壽命，還延長健康壽命。那些結合營養、生物技術和個性化健康洞察，以應對移動性、認知和代謝韌性的公司將塑造健康老齡化和長壽的未來。”</p>
</div><p>The research identifies three high-growth segments transforming the nutraceutical landscape: healthy aging, weight management, and women's health.</p>
<div class="lb-trans"><p>研究確定了三個高增長領域正在改變營養補充品的格局：健康老齡化、體重管理和女性健康。</p>
</div><p>Weight management is evolving beyond traditional calorie reduction strategies toward broader metabolic health optimisation. The report notes that GLP-1-driven innovation is reshaping both the pharmaceutical and nutraceutical industries, creating new opportunities for solutions focused on appetite control, satiety, energy regulation, and sustainable long-term wellness.</p>
<div class="lb-trans"><p>體重管理正在超越傳統的卡路里減少策略，向更廣泛的代謝健康優化發展。報告指出，GLP-1 驅動的創新正在重塑製藥和營養補充品行業，為專注於食慾控制、飽腹感、能量調節和可持續長期健康的解決方案創造新的機會。</p>
</div><p>&#34;As GLP-1 pathways gain traction, weight management is entering a new era of biology-driven solutions,&#34; noted Akheela Dhiman, Industry Analyst, Chemicals, Materials, &amp; Nutrition at Frost &amp; Sullivan.</p>
<div class="lb-trans"><p>“隨着 GLP-1 通路的獲得關注，體重管理正進入一個新的生物驅動解決方案時代，” Frost &amp; Sullivan 的化學、材料與營養行業分析師 Akheela Dhiman 指出。</p>
</div><p>&#34;The emphasis is shifting from short-term results to lasting, holistic well-being, creating new intersections between healthcare and the food and ingredients industry.&#34;</p>
<div class="lb-trans"><p>“重點正在從短期結果轉向持久的整體健康，創造醫療保健與食品和成分行業之間的新交集。”</p>
</div><p>The whitepaper also highlights women's health as one of the industry's most strategically significant growth opportunities, driven by increasing awareness of historically underserved and under-researched health needs spanning fertility, hormonal health, menopause, and metabolic wellness.</p>
<div class="lb-trans"><p>白皮書還強調女性健康是行業中最具戰略意義的增長機會之一，這一機會源於對歷史上被忽視和研究不足的健康需求的日益關注，包括生育、激素健康、更年期和代謝健康。</p>
</div><p>&#34;The women's health market is undergoing a structural reset,&#34; according to Nimisha Dhomne, Industry Analyst, Chemicals, Materials, &amp; Nutrition at Frost &amp; Sullivan.</p>
<div class="lb-trans"><p>“女性健康市場正在經歷結構性重置，” Frost &amp; Sullivan 的化學、材料與營養行業分析師 Nimisha Dhomne 表示。</p>
</div><p>&#34;Life-stage nutrition, biomarker-led insights, and validated ingredients are reshaping innovation priorities, with the emphasis increasingly on precision, credibility, and solutions designed for real physiological complexity.&#34;</p>
<div class="lb-trans"><p>“生命週期營養、基於生物標誌物的洞察和經過驗證的成分正在重塑創新優先事項，重點越來越多地放在精準性、可信度和為真實生理複雜性設計的解決方案上。”</p>
</div><p>Frost &amp; Sullivan identifies several strategic imperatives shaping the future of nutraceuticals, including advances in microbiome science, bioactive ingredients, personalized delivery systems, digital health integration, and direct-to-consumer business models. The report also highlights emerging growth opportunities in perimenopause nutrition, multi-functional healthy aging solutions, and expanding access to nutraceuticals across rapidly growing APAC and Latin American markets.</p>
<div class="lb-trans"><p>Frost &amp; Sullivan 確定了幾個塑造營養補充品未來的戰略要素，包括微生物組科學的進展、生物活性成分、個性化遞送系統、數字健康整合和直銷模式。報告還強調了圍繞圍絕經期營養、多功能健康老齡化解決方案以及在快速增長的亞太和拉丁美洲市場擴大營養補充品獲取的新的增長機會。</p>
</div><p>Leading innovators profiled in the report include dsm-firmenich, Novonesis, Glanbia Nutritionals and Nestlé Health Science, each recognised for advancing ingredient innovation, microbiome science, metabolic health, and life-stage nutrition solutions.</p>
<div class="lb-trans"><p>報告中介紹的領先創新者包括 dsm-firmenich、Novonesis、Glanbia Nutritionals 和 Nestlé Health Science，它們因推動成分創新、微生物組科學、代謝健康和生命週期營養解決方案而受到認可。</p>
</div><p>To claim your complimentary copy of &#34;The Healthspan Economy in Nutraceuticals: Growth Opportunities in Healthy Aging, Women's Health Ingredients, and Weight Management&#34;, click here.</p>
<div class="lb-trans"><p>要索取《營養補充品中的健康經濟：健康老齡化、女性健康成分和體重管理的增長機會》的免費副本，請點擊這裏。</p>
</div><p><strong>About Frost &amp; Sullivan</strong></p>
<div class="lb-trans"><p><strong>關於 Frost &amp; Sullivan</strong></p>
</div><p>Frost &amp; Sullivan, the Transformational Growth Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation, and leadership. The company's Growth Pipeline as a Service provides the CEO's Growth Team with transformational strategies and best-practice models to drive the generation, evaluation, and implementation of powerful growth opportunities. For over 60 years, Frost &amp; Sullivan has partnered with investors, corporate leaders, and governments to identify, prioritise, and execute transformational growth strategies.</p>
<div class="lb-trans"><p>Frost &amp; Sullivan，轉型增長公司，幫助客户加速增長，實現增長、創新和領導力方面的最佳表現。公司的增長管道即服務為首席執行官的增長團隊提供轉型戰略和最佳實踐模型，以推動強大增長機會的生成、評估和實施。超過 60 年來，Frost &amp; Sullivan 與投資者、企業領導者和政府合作，識別、優先考慮和執行轉型增長戰略。</p>
</div><p>Kristina Menzefricke</p>
<div class="lb-trans"><p>Kristina Menzefricke</p>
</div><p>Marketing &amp; Communications</p>
<div class="lb-trans"><p>市場與傳播</p>
</div><p>Global Customer Experience</p>
<div class="lb-trans"><p>全球客户體驗</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>SOURCE Frost &amp; Sullivan</p>
<div class="lb-trans"><p>來源 Frost &amp; Sullivan</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEzJk5ld3NJdGVtSWQ9REE1ODY4NyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTMxNTM1UFJfTkVXU19VU1BSX19fX19EQTU4Njg3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DA58687&amp;Transmission_Id=202605131535PR_NEWS_USPR_____DA58687&amp;DateId=20260513"/></p>

15:35 ETFrost & Sullivan Explores the Rise of the "Healthspan Economy" and Emerging Growth Opportunities in Nutraceuticals

prnewswire

納斯達克生物科技指數 ETF - iShares Nasdaq

標普生物技術 3 倍做多 - Direxion

標普生物技術 ETF - SPDR

動態生物技術與基因組 ETF - Invesco

日常消費品 ETF - SPDR

紐交所高增長板生物技術指數 ETF - First Trust

醫藥突破 ETF - ALPS

2 倍做多納斯達克生物技術 ETF - ProShares

美國消費品 ETF - iShares

生物科技 ETF - VanEck Vectors

Frost & Sullivan 探討 “健康壽命經濟” 的興起以及營養補充劑領域的新興增長機遇